BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30364330)

  • 1. Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities.
    Subbaraman R; de Mondesert L; Musiimenta A; Pai M; Mayer KH; Thomas BE; Haberer J
    BMJ Glob Health; 2018; 3(5):e001018. PubMed ID: 30364330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital Adherence Technologies and Mobile Money Incentives for Management of Tuberculosis Medication Among People Living With Tuberculosis: Mixed Methods Formative Study.
    Musiimenta A; Tumuhimbise W; Atukunda E; Mugaba A; Linnemayr S; Haberer J
    JMIR Form Res; 2023 Apr; 7():e45301. PubMed ID: 37043263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies.
    Alipanah N; Jarlsberg L; Miller C; Linh NN; Falzon D; Jaramillo E; Nahid P
    PLoS Med; 2018 Jul; 15(7):e1002595. PubMed ID: 29969463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation bottlenecks of real time medication monitoring (evriMED) for improving adherence to anti-TB drugs among people with tuberculosis in Kilimanjaro, Tanzania.
    Anenmose Maro R; Mtenga A; Mtesha B; Wilhelm K; Lekashingo N; Sumari-de Boer M; Ngowi K
    J Clin Tuberc Other Mycobact Dis; 2024 Feb; 34():100409. PubMed ID: 38225942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials.
    Ridho A; Alfian SD; van Boven JFM; Levita J; Yalcin EA; Le L; Alffenaar JW; Hak E; Abdulah R; Pradipta IS
    J Med Internet Res; 2022 Feb; 24(2):e33062. PubMed ID: 35195534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and acceptability of the smart pillbox and medication label with differentiated care to support person-centered tuberculosis care among ASCENT trial participants - A multicountry study.
    Tadesse AW; Mganga A; Dube TN; Alacapa J; van Kalmthout K; Letta T; Mleoh L; Garfin AMC; Maraba N; Charalambous S; Foster N; Jerene D; Fielding KL
    Front Public Health; 2024; 12():1327971. PubMed ID: 38444445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of a Digital Adherence Tool Among Patients With Tuberculosis and Tuberculosis Care Providers in Kilimanjaro Region, Tanzania: Mixed Methods Study.
    Mtenga AE; Maro RA; Dillip A; Msoka P; Emmanuel N; Ngowi K; Sumari-de Boer M
    Online J Public Health Inform; 2024 Jun; 16():e51662. PubMed ID: 38922643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital monitoring technologies could enhance tuberculosis medication adherence in Uganda: Mixed methods study.
    Musiimenta A; Tumuhimbise W; Mugaba AT; Muzoora C; Armstrong-Hough M; Bangsberg D; Davis JL; Haberer JE
    J Clin Tuberc Other Mycobact Dis; 2019 Dec; 17():100119. PubMed ID: 31788561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
    Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Blumberg HM; Marconi VC
    Trials; 2020 May; 21(1):383. PubMed ID: 32370774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of a comprehensive package based on electronic medication monitors at improving treatment outcomes among tuberculosis patients in Tibet: a multicentre randomised controlled trial.
    Wei X; Hicks JP; Zhang Z; Haldane V; Pasang P; Li L; Yin T; Zhang B; Li Y; Pan Q; Liu X; Walley J; Hu J
    Lancet; 2024 Mar; 403(10430):913-923. PubMed ID: 38309280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using a Mobile Health Intervention (DOT Selfie) With Transfer of Social Bundle Incentives to Increase Treatment Adherence in Tuberculosis Patients in Uganda: Protocol for a Randomized Controlled Trial.
    Sekandi JN; Onuoha NA; Buregyeya E; Zalwango S; Kaggwa PE; Nakkonde D; Kakaire R; Atuyambe L; Whalen CC; Dobbin KK
    JMIR Res Protoc; 2021 Jan; 10(1):e18029. PubMed ID: 32990629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Explaining Differences in the Acceptability of 99DOTS, a Cell Phone-Based Strategy for Monitoring Adherence to Tuberculosis Medications: Qualitative Study of Patients and Health Care Providers.
    Thomas BE; Kumar JV; Onongaya C; Bhatt SN; Galivanche A; Periyasamy M; Chiranjeevi M; Khandewale AS; Ramachandran G; Shah D; Haberer JE; Mayer KH; Subbaraman R
    JMIR Mhealth Uhealth; 2020 Jul; 8(7):e16634. PubMed ID: 32735220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial.
    Tadesse AW; Mohammed Z; Foster N; Quaife M; McQuaid CF; Levy J; van Kalmthout K; van Rest J; Jerene D; Abdurhman T; Yazew H; Umeta DG; Assefa D; Weldemichael GT; Bedru A; Letta T; Fielding KL
    BMC Infect Dis; 2021 Nov; 21(1):1149. PubMed ID: 34758737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobile Health for Tuberculosis Management in South India: Is Video-Based Directly Observed Treatment an Acceptable Alternative?
    Kumar AA; De Costa A; Das A; Srinivasa GA; D'Souza G; Rodrigues R
    JMIR Mhealth Uhealth; 2019 Apr; 7(4):e11687. PubMed ID: 30942696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability of using the medication monitor and experience of a differentiated care approach for TB treatment adherence among people living with TB in South Africa.
    Mukora R; Ahumah B; Maraba N; Orrell C; Jennings L; Naidoo P; Fielding KL; Velen K; Charalambous S; Chetty-Makkan CM
    PLOS Glob Public Health; 2023; 3(10):e0001885. PubMed ID: 37889875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital Health Interventions to Enhance Tuberculosis Treatment Adherence: Scoping Review.
    Lee S; Rajaguru V; Baek JS; Shin J; Park Y
    JMIR Mhealth Uhealth; 2023 Dec; 11():e49741. PubMed ID: 38054471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers.
    Thomas BE; Kumar JV; Periyasamy M; Khandewale AS; Hephzibah Mercy J; Raj EM; Kokila S; Walgude AS; Gaurkhede GR; Kumbhar JD; Ovung S; Paul M; Rajkumar BS; Subbaraman R
    J Med Internet Res; 2021 Jun; 23(6):e23294. PubMed ID: 34110300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective single-arm interventional pilot study to assess a smartphone-based system for measuring and supporting adherence to medication.
    Molton JS; Pang Y; Wang Z; Qiu B; Wu P; Rahman-Shepherd A; Ooi WT; Paton NI
    BMJ Open; 2016 Dec; 6(12):e014194. PubMed ID: 27998903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial.
    Liu X; Lewis JJ; Zhang H; Lu W; Zhang S; Zheng G; Bai L; Li J; Li X; Chen H; Liu M; Chen R; Chi J; Lu J; Huan S; Cheng S; Wang L; Jiang S; Chin DP; Fielding KL
    PLoS Med; 2015 Sep; 12(9):e1001876. PubMed ID: 26372470
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.